PH

Payal Hemal Nayak

Director Director DIN 09181697
DIN 09181697 First appointment May 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Payal Hemal Nayak

Data last updated:

Payal Hemal Nayak has 5 years in corporate governance. Formerly with 1 company, such as Supreme Pathology Lab Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09181697
Primary Designation Director
First Appointment 22 May 2021
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 May 20212021₹0.57 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Supreme Pathology Lab Private Limited
Premium access

Shareholding and investment profile for Payal Hemal Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payal Hemal Nayak

Payal Hemal Nayak has 5 years in corporate governance. Formerly with 1 company, such as Supreme Pathology Lab Private Limited. Engaged in General Business. Contributes to corporate operations.

Payal Hemal Nayak is associated with 0 companies as a director.

Payal Hemal Nayak has expertise in General Business.

Payal Hemal Nayak has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available